Neogenomics Inc (NEO)

EBITDA Margin

1.68%

TTM · Period ending:

NEO logo

NEO EBITDA Margin

Latest reported1.68%
NEO TTM EBITDA Margin (-237.07% → 1.68%)
High-resolution chart · PNG

NEO ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Neogenomics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-900.6797%
-374.133%
-237.0697%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.